about
Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic studyClinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trialPublisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
P50
description
researcher ORCID ID = 0000-0002-9668-6689
@en
wetenschapper
@nl
name
Aaron Prendergast
@ast
Aaron Prendergast
@en
Aaron Prendergast
@es
Aaron Prendergast
@nl
type
label
Aaron Prendergast
@ast
Aaron Prendergast
@en
Aaron Prendergast
@es
Aaron Prendergast
@nl
prefLabel
Aaron Prendergast
@ast
Aaron Prendergast
@en
Aaron Prendergast
@es
Aaron Prendergast
@nl
P21
P31
P496
0000-0002-9668-6689